ELIQUIS β Apixaban 2.5 mg Tablet
Powered by Ernest Pharmaceutical Group
(All brands under Ernest Pharmaceutical Pvt. Ltd.)
@ERNESTVISION | ERNEST PHARMACEUTICAL PVT. LTD.
For global exports, OEM branding & distributor partnerships
π§ Email: exports@ernestpharmaceuticals.com
@ERNESTIMPEXPHARMACEUTICALPVTLTD
For bulk quotations, availability, and orders, please contact us:
π§ Email: exports@ernestpharmaceuticals.com
π www.ernestpharmaceuticals.com | www.ernestimpex.com
Amit Rai: WhatsApp link https://wa.me/message/M6GESWXSIOZMD1
π² WhatsApp: βͺβͺβͺ+91 94054 76170
Product Description
ELIQUIS Tablet contains Apixaban 2.5 mg, an oral anticoagulant belonging to the class of direct factor Xa inhibitors. It is used in physician-supervised medical settings to help reduce the risk of blood clot formation in patients requiring anticoagulation therapy at a lower dose strength.
Apixaban selectively inhibits factor Xa, an essential component of the coagulation cascade, thereby reducing thrombin generation and clot development. The 2.5 mg strength is commonly prescribed for dose-adjusted therapy, including elderly patients or those with specific clinical considerations.
ELIQUIS 2.5 mg tablets are formulated to provide accurate dosing, predictable bioavailability, and consistent quality, making them suitable for regulated pharmaceutical distribution, wholesale trade, and export supply.
Composition
Active Ingredient: Apixaban
Strength: 2.5 mg
Dosage Form: Tablet
Mechanism of Action
Apixaban works by selectively and reversibly inhibiting factor Xa, preventing the conversion of prothrombin into thrombin. This action reduces fibrin clot formation without directly affecting platelet aggregation.
Indications/Uses
Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (as prescribed)
Prevention of venous thromboembolism following orthopedic surgery
Dose-adjusted anticoagulant therapy in selected patients
Prevention of recurrent blood clots (as directed by a physician)
Key Features
β Direct oral anticoagulant (DOAC)
β Lower-dose 2.5 mg strength for tailored therapy
β Predictable anticoagulant effect
β No routine coagulation monitoring required (as prescribed)
β Suitable for Distributor, Wholesale Supplier & Bulk Supplier channels
Dosage & Administration
Dosage and duration should be individualized by a qualified healthcare professional, considering patient age, renal function, body weight, and clinical condition.
Storage Instructions
Store in a cool, dry place
Protect from moisture and direct sunlight
Keep out of reach of children
Packaging
Blister/strip packing
Bulk packaging available for institutional and export supply
Documentation Details (Available on Request)
Certificate of Analysis (COA)
Material Safety Data Sheet (MSDS)
Batch Manufacturing Record (BMR)
Batch Release Certificate
Product Specification Sheet
Certificate of Origin (COO)
Commercial Invoice & Packing List
Why Choose Ernest Pharmaceutical Pvt. Ltd.?
π ISO-Certified Global Exporter
π 10+ Years of International Healthcare Export Experience
π Private Label & OEM Supply Options
π Complete Regulatory Documentation (COA, COPP, COO, MSDS, etc.)
π Temperature-Controlled International Logistics via DHL, FedEx & Aramex
Payment & Logistics
π± Accepted Payment Modes
TT (Telegraphic Transfer)
International Bank Transfer
π Fast Dispatch & Worldwide Delivery Available
Contact for Bulk Orders & Latest Price
Ernest Pharmaceutical Pvt. Ltd.
π§ Email: exports@ernestpharmaceuticals.com